Search Close Search
Search Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • Fen-Biao Gao details how frontotemporal dementia changes the brain and explores its genetic causes

    Fen-Biao Gao details how frontotemporal dementia changes the brain and explores its genetic causes

    In an updated article originally published by The Conversation in Feb. 2023, Fen-Biao Gao, PhD, talks about how frontotemporal dementia changes the brain and the research that is untangling its genetic causes.

    Read more
  • PODCAST: Understanding the connection between the gut microbiome and Alzheimer’s

    PODCAST: Understanding the connection between the gut microbiome and Alzheimer’s

    In a new Voices of UMass Chan podcast, John P. Haran, MD’07, PhD’18, and Ethan Loew, MD/PhD student, shed light on their ongoing research to better understand the connection between the gut microbiome and cognitive health, particularly how it impacts older people.

    Transcript

    Read more
  • UMass Chan researchers earn PolyBio Foundation award for long COVID, neurodegenerative disease study

    UMass Chan researchers earn PolyBio Foundation award for long COVID, neurodegenerative disease study

    The scientists will use a human cerebral organoid platform to evaluate the role of COVID in neurodegenerative diseases, such as Alzheimer’s, Parkinson’s and dementia 

    Read more
  • Science for Living: What to know about Ozempic and other weight loss drugs

    Science for Living: What to know about Ozempic and other weight loss drugs

    A class of drugs designed to help patients manage diabetes also promotes weight loss, a feature that has made them wildly popular among many who want to shed some pounds. Samir Malkani, MD, from UMass Chan and UMass Memorial Health’s Diabetes Center of Excellence highlights what to know about these drugs.

    Read more
  • Kirschstein award funds MD/PhD student’s research on opioid use disorder

    Kirschstein award funds MD/PhD student’s research on opioid use disorder

    MD/PhD student Pryce Michener has received a Ruth L. Kirschstein National Research Service Award for his research on substance use and medications for opioid use disorder, a personal cause that has impacted his friends and family. 

    Read more
  • Postdoc Rebecca Beiter’s neurodegenerative research funded by Kirschstein Award

    Postdoc Rebecca Beiter’s neurodegenerative research funded by Kirschstein Award

    Rebecca Beiter, PhD, a postdoc in the lab of Dorothy P. Schafer, PhD, has received an award from the National Institute of Neurological Disorders and Stroke to analyze the role a type of brain cell plays in neurodegenerative diseases such as multiple sclerosis.

    Read more